iiinova — where your digital self keeps evolving

SWOG Cancer Research Network @swog.org · 20/08/2026

“Federal and Industry Sponsorship in US Cancer Clinical Trials,” Aug 20th in @jamaoncology.com. A comparative study of cancer clinical trial portfolios supported by federal versus industry funding characterizes their distinct, interdependent roles. doi.org/10.1001/jama...

doi.org

Federal and Industry Sponsorship in US Cancer Clinical Trials

This comparative study of cancer clinical trial portfolios assesses differences between federal and industry sponsors in cancer clinical trial research.

000

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 14/08/2026

Impressive! "A recent review of the SLAI portfolio identified 25 studies that have been approved for SLAI participation since 2020...From 2010 to 2019, only four SWOG studies had SLAI accrual, and generally, only one study was ever accruing at a time" @swog.org #SWOGonc More➡️ tinyurl.com/SLAIaug26

011

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 01/06/2026

SWOG is 70 Years Strong! This year marks the 70th anniversary of the founding of the cooperative group that would go on to become the SWOG Cancer Research Network #SWOGonc @swog.org www.swog.org/.../2026/05/...

031

SWOG Cancer Research Network @swog.org · 29/05/2026

Lung-MAP investigators present 4 posters at #ASCO26. 1 is an analysis led by Dr. Diane Tseng of how the severity of immune-related adverse events (irAEs) in patients getting ICIs is associated with clinical outcomes: www.asco.org/abstracts-pr...

030

SWOG Cancer Research Network @swog.org · 28/05/2026

SWOG researchers give #ASCO26 oral presentations on results of 2 GI trials, a testicular cancer study, work on vit D & neuropathy, big-picture results from S1609 DART rare cancers trial, & an AI prediction model in breast cancer! @swog.org ASCO calendar is at swog.org/media/26051.

022

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 28/05/2026

We want your great ideas! Our annual call for funding proposals has opened. Now through September 1, we welcome submissions from @swog.org members and collaborators #SWOGonc Learn more: conta.cc/4tSPFH3

A graphic that reads, Have a great idea? Submit a proposal and get it funded. Apply by September 1. thehopefoundation.org

011

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 12/05/2026

Did you catch the recap from the @swog.org spring meeting? We made a big announcement honoring Dr. Blanke! (and there was cake 🍰) #SWOGonc www.swog.org/news-events/...

Drs. Lara, Hershman, and Blanke (L-R) at the Friday evening reception.

011

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 30/04/2026

If you're here in San Francisco for the #SWOGonc meeting don't forget to leave a message for Dr. Blanke! Share a memory or best wishes for our @swog.org Group Chair Emeritus 🎉

A table with memory book for Dr. Blanke inviting meeting attendees to sign with memories and best wishes.

011

Reposted by SWOG Cancer Research Network

gretchenmcnally.bsky.social @gretchenmcnally.bsky.social · 30/04/2026

Excited for the @swog.org spring meeting, thanks to @supportingswog.bsky.social- kicking things off with the #palliative committee. #oncology #nurse #nursepractitioner #research #scientists

121

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 27/04/2026

Apply by May 1: All #NCTN group members are eligible! @swog.org Virtual Grant Writing Workshop #SWOGonc conta.cc/3Qqnm4M

022

Reposted by SWOG Cancer Research Network

UChicago Cancer @uchicagocancer.bsky.social · 24/04/2026

Thrilled and proud that our Hematology/Oncology Section Chief Dr. Smith has been selected as the Chair of @swog.org's lymphoma committee!! She is an incredible leader and very much deserves this honor!

011

SWOG Cancer Research Network @swog.org · 17/04/2026

"Lung-MAP is the most transformative & pivotal trial in the MET Crusaders right now." Hear MET Crusaders Chair Marcia K. Horn, JD, on 3 Lung-MAP studies for patients with advanced non-small cell #lungcancer with MET biomarkers. #lcsm #ClinicalTrials @focr.bsky.social www.youtube.com/watch?v=H1mx...

youtube.com

Why Lung MAP Matters for MET Lung Cancer Patients

YouTube video by Friends of Cancer Research

010

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 13/04/2026

Team Hope showed up and gave it their all! 62 or 32 miles through the hills (and wind!) at the #TourDeScottsdale Every mile 🚴‍♀️ to advance @swog.org research #SWOGonc Proud of this crew! Grateful for everyone who donated & cheered us on 🙌 Watch the recap ⬇️ vimeo.com/1180550865?f...

vimeo.com

Team Hope at the 2026 Tour de Scottsdale

The Hope Foundation's 3rd annual Team Hope Ride at the 2026 Tour de Scottsdale.

011

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 13/04/2026

A new chair for @swog.org 's lymphoma committee #SWOGonc "Please join us in welcoming Dr. Smith as chair of SWOG’s lymphoma committee, and in thanking outgoing chair Dr. Jonathan W. Friedberg for his visionary leadership of our lymphoma research effort." www.swog.org/news-events/...

swog.org

A Changing of SWOG’s Lymphoma Guard | SWOG

After a national search chaired by our group statistician Dr. Mike LeBlanc, we have just selected Dr. Sonali M. Smith to be chair of SWOG’s lymphoma committee. Pending approval by the board of governo...

021

SWOG Cancer Research Network @swog.org · 01/04/2026

S2409 PRISM is testing whether it’s feasible to identify each patient’s small cell #LungCancer subtype and use that information to select the best therapy for that patient. #SCLC Co-PI: Alberto Chiappori, MD @moffittnews.bsky.social swog.org/clinical-trials/S2409

020

SWOG Cancer Research Network @swog.org · 31/03/2026

Thank you to all riders, donors, and other supporters of @supportingswog.bsky.social and @swog.org in this event! And huge thanks to Dr. Parminder Singh for getting all of this rolling!

000

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 23/03/2026

From the @swog.org Front Line: SWOG Establishes An APP & Nurse Scientist Committee #SWOGonc "Drs. Myers and Braun-Inglis are, of course, the ideal leadership team for this committee..." We agree! 💯 Congrats to this powerhouse team! www.swog.org/news-events/...

Christa Braun-Inglis (L) and Jamie Myers at the spring 2023 SWOG group meeting in San Francisco. Photo by Fred Joe.

011

SWOG Cancer Research Network @swog.org · 24/03/2026

Blog post from SWOG chairs @drdawnhershman.bsky.social & Primo N. Lara, MD: SWOG Establishes An APP & Nurse Scientist Cmte Our new cmte recognizes the contributions of APPs to our success & will help empower more of them to contribute to their full scope of practice. www.swog.org/news-events/...

011

SWOG Cancer Research Network @swog.org · 20/03/2026

March 20, 2026: FDA approves nivolumab + AVD combination for Stage III or IV classical Hodgkin lymphoma in patients 12 and older, based on results of phase 3 S1826 #NCTN NCI trial, led by SWOG Cancer Research Network @swog.org and Children's Oncology Group (COG): www.fda.gov/drugs/resour...

fda.gov

FDA approves nivolumab with chemotherapy for Hodgkin lymphoma

FDA approved approved nivolumab (Opdivo, Bristol Myers Squibb Company) with doxorubicin, vinblastine, and dacarbazine (AVD) for cHL.

021

SWOG Cancer Research Network @swog.org · 19/03/2026

Front Line post from @swog.org group chairs @drdawnhershman.bsky.social & Primo N. Lara, MD: The Next Era of SWOG Success In our vision, we focus even more intensively on studies that tackle the vital questions only public-powered research will answer. www.swog.org/news-events/...

012

SWOG Cancer Research Network @swog.org · 09/03/2026

Our @swog.org Chairs' blog: A Team Science Leadership Team SWOG is all about interdisciplinary collaboration and team science. We think a leadership approach with dual principal investigators who bring complementary skillsets and expertise to the role is a great fit. www.swog.org/news-events/...

021

SWOG Cancer Research Network @swog.org · 04/03/2026

Saying Thank You: Dr. Charles Blanke's last Front Line post as chair of @swog.org: "I have been honored to serve as chair of this research group over the last 13 years, and I could not be prouder of what you have accomplished in that time." www.swog.org/news-events/...

021

Reposted by SWOG Cancer Research Network

Fred Hutch @fredhutch.org · 02/03/2026

Follicular lymphoma has long been deemed incurable. New findings from a 15-year follow-up analysis of clinical trial patients with follicular lymphoma could upend that prediction. @mshadman.bsky.social @swog.org Read more: bit.ly/4rIb59x

021

SWOG Cancer Research Network @swog.org · 25/02/2026

Registration is open for SWOG's spring group meeting, April 30-May 2, in San Francisco! Incoming Group Chairs Drs. Primo Lara, Jr., & Dawn Hershman invite SWOG members to bring questions, concerns, & ideas to an interactive town hall-style plenary, Friday, May 1, 2-4pm PT. Details: swog.org/Sp26mtg

100

SWOG Cancer Research Network @swog.org · 13/01/2026

"Cancer statistics, 2026: Charting a course for a national cancer research agenda," commentary by Dr. Primo Lara, Jr, & @drdawnhershman.bsky.social publ w the annual portrait of U.S. #cancer stats in CA: A Cancer Journal for Clinicians, just out! #NCTN #NCORP @eaonc.bsky.social @nrgonc.bsky.social

doi.org

Cancer statistics, 2026: Charting a course for a national cancer research agenda

Click on the article title to read more.

021

SWOG Cancer Research Network @swog.org · 12/01/2026

S2213 is a randomized ph 3 to definitively learn role of transplant in pts newly diagnosed w AL #amyloidosis. BMT-CTN Champion: Anita D'Souza, MD SWOG.org/clinical-trials/S2213

020

SWOG Cancer Research Network @swog.org · 09/01/2026

Treated for muscle invasive bladder cancer and want to keep your bladder? Ask your doctor about #ClinicalTrial S2427 (BRIGHT). SWOG.org/S2427. 1-800-4-CANCER. #KeepMyBladder #MIBC

000

SWOG Cancer Research Network @swog.org · 08/01/2026

Extensive stage small cell lung cancer can be hard to treat — but study S2409 (the PRISM trial) is looking for better, personalized options. To learn more, visit SWOG.org/S2409 or call 1-800-4-CANCER. #LCSM #SCLC

000

SWOG Cancer Research Network @swog.org · 06/01/2026

S2213 is an #ALamyloidosis #clinicaltrial to determine if Dara-VCD drug treatment or stem cell transplant is better for patients. The study may be an option for you if your treatment plan could safely include a stem cell transplant. Learn more at SWOG.org/S2213. Or call 1-800-4- CANCER.

000

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 03/01/2026

For all #SWOGonc early career GU researchers: The Nicholas Vogelzang GU Scholars Program Includes mentorship and travel support - apply by January 15 w/ @swog.org thehopefoundation.org/vogelzang-gu...

031

SWOG Cancer Research Network @swog.org · 02/01/2026

#ClinicalTrial S2409 (PRISM) asks if it’s possible to personalize treatment for extensive stage small cell lung cancer. It compares standard treatment alone to standard treatment plus a drug matched to the cancer subtype. Learn more: SWOG.org/S2409 or 1-800-4-CANCER.

010

SWOG Cancer Research Network @swog.org · 01/01/2026

Have you had treatment for muscle invasive #BladderCancer? Are you expecting surgery next? If your scans show no cancer, you may be able to join #ClinicalTrial S2427 (also called BRIGHT). Visit SWOG.org/S2427 to learn more. Or call 1-800-4-CANCER. #BladderPreservation

010

Reposted by SWOG Cancer Research Network

Fred Hutch @fredhutch.org · 30/12/2025

In a multi-trial analysis led by Fred Hutch's Dr. Joe Unger, patients reporting fatigue prior to systemic cancer treatment faced 2x the risk for severe toxic effects and nearly 5x the risk for fatal complications compared with those with minimal to no fatigue. @swog.org wb.md/3LozLE8

wb.md

Fatigue Before Cancer Therapy Predicts Toxicity Risk

Patients' fatigue levels before starting systemic cancer treatment predict their risk for severe or fatal side effects.

011

SWOG Cancer Research Network @swog.org · 30/12/2025

Just activated! #NCTN S2433 trial is enrolling patients with locally advanced or metastatic #pancreatic ductal adenocarcinoma without KRAS or BRAF V600E mutations. Randomized to physician’s choice SOC w/wo panitumumab. #pancsm PI: Rachael A. Safyan, MD @fredhutch.org swog.org/clinical-tri...

011

SWOG Cancer Research Network @swog.org · 29/12/2025

In @jamaoncology.com: higher baseline fatigue assoc w higher risk of severe #cancer treatment-related toxic effects. Initial fatigue assessment may be early marker of risk for SAEs & inform personalized therapy. @drjoeunger.bsky.social @drdawnhershman.bsky.social @fischmd.bsky.social @fredhutch.org

031

SWOG Cancer Research Network @swog.org · 29/12/2025

S2213 is a randomized ph 3 to definitively learn the role of transplant in pts newly diagnosed w AL #amyloidosis. ECOG-ACRIN Cancer Research Group Champion: Taxiarchis Kourelis, MD SWOG.org/clinical-trials/S2213

010

SWOG Cancer Research Network @swog.org · 24/12/2025

Bladder removal surgery can have a big impact on quality of life. Study S2427 (also called BRIGHT) is testing a possible #BladderSparing approach for people with muscle invasive #BladderCancer. To learn more, visit SWOG.org/S2427 or call 1-800-4-CANCER. #MIBC

000

Reposted by SWOG Cancer Research Network

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 19/12/2025

Our program offerings kick off right away in 2026. #SWOGonc members, please don't miss our January 15 deadline for CRA and nurse travel to the spring @swog.org group meeting! thehopefoundation.org/funding-oppo...

011

SWOG Cancer Research Network @swog.org · 23/12/2025

If you have extensive stage small cell lung cancer (ES-SCLC) and you haven’t started initial treatment, ask your doctor about study S2409 (PRISM). It tests the cancer for certain features to match patients with treatments. SWOG.org/S2409. 1-800-4-CANCER. #LCSM #SCLC

000

SWOG Cancer Research Network @swog.org · 22/12/2025

Study S2213 asks if a drug combination known as Dara-VCD or stem cell transplant is better for treating AL #amyloidosis. It tests how well the treatments work, and how they affect quality of life. Learn more at SWOG.org/S2213. Or call 1-800-4-CANCER. #raredisease #clinicaltrial

000

SWOG Cancer Research Network @swog.org · 19/12/2025

Our #TranslationalMedicine Link of the Week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: FDA–AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials doi.org/10.1158/1078...

010

SWOG Cancer Research Network @swog.org · 19/12/2025

#ClinicalTrial S2409 PRISM randomizes patients with extensive stage small cell lung cancer to durvalumab with or without a drug that’s targeted to their specific #SCLC subtype. Co-PI: Nan Sethakorn, MD, PhD - Loyola Univ Medical Center swog.org/clinical-trials/S2409

010

SWOG Cancer Research Network @swog.org · 18/12/2025

S2427 BRIGHT trial tests IO + RT as bladder-preserving tx for patients with MIBC who respond to NAT. PROs track QoL and treatment-related symptomatic toxicities. Systematic biopsies needed at post-NAT TURBT. Co-PI: James B. Yu, MD, MHS, Dartmouth Cancer Center swog.org/clinical-trials/S2427

000

SWOG Cancer Research Network @swog.org · 17/12/2025

If you have extensive stage small cell lung cancer (ES-SCLC) and you haven’t finished initial treatment, ask your doctor about study S2409 (PRISM). It tests the cancer for certain features to match patients with treatments. SWOG.org/S2409. 1-800-4-CANCER. #LCSM #SCLC

000

SWOG Cancer Research Network @swog.org · 16/12/2025

Are you getting treatment for muscle invasive bladder cancer? Ask your doctor about S2427 (BRIGHT). It’s a #ClinicalTrial testing whether an immunotherapy drug plus radiation therapy can help patients keep their bladder. SWOG.org/S2427. 1-800-4-CANCER. #MIBC

001